About Us

Pacific Marine Biotech (PMB) is a United States-based biotech company founded in December 2021 by Samuel Grant and Alan Temkin. Our team’s mission is to provide a safe and natural treatment solution for DIPG and Glioblastoma that restores Quality of Life by securing FDA orphan drug approval for Immune12.

PMB’s immediate objective is to create partnerships with leading healthcare institutions in the United States for the purpose of conducting clinical trials on Immune12. We envision a future in which we can positively change the way cancer is treated, rewriting the narrative for thousands of cancer patients every year and for the betterment of communities around the world.

Board of Directors

Samuel Grant

Samuel Grant, Co-Founder and President

Sam Grant founded Unicorn Pacific Marketing with his father, Sam Grant Sr., nearly 40 years ago. Their mission was to manufacture and distribute Immune12 — which cured Sam Grant Sr.’s terminal stomach cancer in 1962 — and help other people around the globe who are facing a cancer diagnosis. Prior to forming PMB, Sam took Immune12 through US-based FDA clinical trials for multiple myeloma and was granted Orphan Drug designation in 2012. It is one of a handful of natural products to have orphan designation to treat specific cancer patients.

Also on the Advisory Board

Alan Temkin

Alan Temkin, Chief Executive Officer

After seeing Immune12’s positive results with brain cancer, Alan felt a profound responsibility to co-found PMB to help others in need. For over 50 years, Alan has been a leader in Connecticut’s building and development industry. As director and CEO of the Alan Temkin Group, he has partnered with multiple companies to build more than 1,500 new homes across the state, along with land and infrastructure development. He is on the Board of Directors for Brooker Memorial, an institution dedicated to improving the lives of children, and has served as President of the Northwestern Connecticut Chamber of Commerce.

Also on the Advisory Board

Jim Sok

James E. Sok, EVP & Secretary

From the front line to the C-suite, James Sok brings medical industry insight and structured professionalism to PMB. After an early career as a pharmacist, he went onto serve at the highest levels of healthcare leadership, with a track record of improving profitability, visibility and performance at health systems along the East coast. He is a former president and CEO of numerous hospitals, including Sharon Hospital in Sharon, CT, and Sheltering Arms Corporation in Richmond, VA. He also served as executive vice president of Good Shepherd Rehabilitation Network Healthcare, a regional rehabilitation leader with more than 70 locations in Pennsylvania and New Jersey.

Ray Oneglia

Ray Oneglia

Ray Oneglia is a skilled businessman and expert in the construction and materials industries. Through astute acquisitions and joint venture partnerships, he has helped grow his family business, O&G Industries, into a nationally-recognized entity. He is a trusted partner for industry leaders like Tutor Perini, where he serves on the board of directors. He is also a respected resource on local and national policy, with key roles in organizations like the Connecticut Construction Industries Association, the Hudson Institute and the Business Executives for National Security.

Chris Wilson

Chris Wilson

Chris Wilson is a financial and business expert who is committed to investing in the well-being of others. Before retirement, he served for almost 30 years as senior partner at the investment firm Stonehill Capital Management, building it from less than $100 million in assets to over $3.5 billion. He is the founder and trustee of the Wilson Sheehan Foundation, which strives to build educational, economic and other opportunities for people living in low-income homes and communities.

Advisory Board

Peter Jerin

Peter Jerin

Peter Jerin is a former international business executive known for his business prowess and financial acumen. He had a long, diverse career across eight divisions on three continents with General Electric. His experience includes managing the team that built the very first magnetic resonance imaging (MRI) machine, Managing Director for GE and Malaysia Airlines successful joint venture, and executive leader of teams across 14 EU countries. He completed his executive corporate career at Gulfstream Aerospace successfully leading global procurement teams that supported current and new aircraft design and production. In addition to his expertise in organizational design and business development, Peter also has a cum laude degree in Industrial Engineering where he was selected for Who’s Who in American Colleges and Universities.

Dan McIntyre

Daniel McIntyre

Daniel McIntyre, a former healthcare executive who leads recruitment for PMB’s medical oncology team, is known for innovating. As a healthcare leader, he piloted strategic transformations at numerous Connecticut health providers. Most recently, that included a 20-year term as president and CEO of Charlotte Hungerford Hospital, where he oversaw the successful merger with Hartford Healthcare. With a background in engineering, Dan has also contributed to numerous inventions in aerospace, machine tool technologies and electromechanics.

Medical Advisory Board

Magnifico

Michael C. Magnifico, MD, Medical Advisor

Michael Magnifico, MD, holds three board certifications: internal medicine, medical oncology and hematology. During his decades of clinical practice, he directly cared for patients throughout northwest Connecticut, notably at Sharon Hospital, Charlotte Hungerford Hospital and New Milford Hospital; and served as medical director of the VNA Hospice in Torrington for 30 years.

Dr. Magnifico received his baccalaureate of medical sciences from Dartmouth Medical School and obtained his medical degree from Columbia University College of Physicians and Surgeons. His residencies in medicine and anatomic pathology were at Columbia Presbyterian Medical Center, and he completed his fellowships in medical oncology and hematology at the Yale School of Medicine.